PHARPharming Group N.V.
PHAR holders
Who holds Pharming Group N.V., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Moves this quarter
Added
Reduced
- Silverberg Bernstein Capital Management LLC−5.8K$357.5K
- Silver Grove Financial Group, Inc.−1K$579
- Morgan Stanley−1K$104.8K
New
- Calydon Capital1.2K$11.5K
- Tower Research Capital LLC (TRC)241$2.4K
- Managers
- 9
- Shares held
- 73K
- Value held
- $729.3K
- Opened
- 2
- Closed
- 8
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | 35.8K | −13.9% | $357.5K | 0.2% | Oct 13, 2026 |
| Crossmark Global Holdings, Inc. | 12.5K | ±0% | $124.5K | 0.1% | Oct 21, 2026 |
| Morgan Stanley | 10.5K | −8.7% | $104.8K | 0% | Nov 13, 2026 |
| BNP Paribas Financial Markets | 8.7K | +2,801.7% | $87K | 0% | Nov 12, 2026 |
| Knoll Capital Management, LLC | 4.1K | ±0% | $40.9K | 0.1% | Nov 16, 2026 |
| Calydon Capital | 1.2K | New | $11.5K | 0.1% | Nov 16, 2026 |
| Tower Research Capital LLC (TRC) | 241 | New | $2.4K | 0% | Nov 16, 2026 |
| Silver Grove Financial Group, Inc. | 58 | −94.6% | $579 | 0.1% | Nov 5, 2026 |
| Caitong International Asset Management Co., Ltd | 13 | +1,200.0% | $130 | 0% | Oct 29, 2026 |